Interestingly, recent reports have shown that increased plasma p-tau 217 is the most sensitive biomarker for predicting future cognitive decline at the preclinical stage,77 while increased plasma p-tau 181 is the most sensitive biomarker for predicting cognitive worsening at the prodromal stage.31,43. Here, MAPT is linked to Mental deterioration.